-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Immunic, Maintains $6 Price Target

Benzinga·04/16/2025 17:26:14
Listen to the news
B. Riley Securities analyst William Woods reiterates Immunic (NASDAQ:IMUX) with a Buy and maintains $6 price target.